![](/img/cover-not-exists.png)
847OA phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma
Lee, C-H., Makker, V., Rasco, D., Taylor, M., Dutcus, C., Shumaker, R., Schmidt, E.V., Stepan, D., Li, D., Motzer, R.J.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx371.002
Date:
September, 2017
File:
PDF, 87 KB
english, 2017